|
WO2019108484A2
|
|
Methods and compositions for modulating melanogenesis
|
|
WO2018085565A2
|
|
Short bioactive peptides blocking activity of advanced glycation end products, compositions, and methods of use
|
|
US2017007662A2
|
|
Tetrapeptides Derived from Human C-X-C Chemokines Useful for Treatment of Various Skin Conditions
|
|
CN105324122A
|
|
Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions
|
|
NZ711281A
|
|
Short bio-active peptides for promoting wound healing
|
|
AU2013235692A1
|
|
Short antimicrobial lipopeptides
|
|
AU2012216555A1
|
|
Peptide fragments for inducing synthesis of extracellular matrix proteins
|
|
AU2011271466A1
|
|
N-acyl amino acid derivatives for treating skin conditions such as cellulite
|
|
CN102791281A
|
|
Peptide protection against ultraviolet light toxicity
|
|
KR20100083828A
|
|
Protective skin care tetrapeptides
|
|
CN101679495A
|
|
Short bio-active peptides for cellular and immunological modulation
|
|
MX2008016011A
|
|
Peptide fragments for inducing synthesis of extracellular matrix proteins.
|
|
CN101155825A
|
|
Antimicrobial hexapeptides
|
|
EP2105141A1
|
|
Short bioactive peptides and methods for their use
|
|
US6875744B2
|
|
Short bioactive peptides
|
|
US5861478A
|
|
Lytic peptides
|
